In plain language
In a randomized trial of 136 complex catheter ablations at one center, a newer image processing system lowered patient dose by about 40% and operator dose by about half, with similar procedure times and success rates.
At a glance
- Type of study
- Original research, Randomized trial
- Who was studied
- Patients, Electrophysiologists
- Size
- n = 136 patients
- Summary based on
- the abstract
What it found
Patient dose (DAP and air kerma) was substantially lower with the novel image processing technology than with the reference system.
Key figures: 43% (DAP) and 40% (AK) lower; P < .0001
Operator dose was halved with the novel imaging technology.
Key figures: 50% reduction; P < .001
Fluoroscopy time, exposure frames and procedure duration were equivalent, suggesting image quality was similarly adequate.
Procedural success was the same in both groups.
Key figures: 91% in both groups
Limits to keep in mind
Single-center, unblinded trial with modest sample; operator dose was a secondary end-point, and the groups differed in age. Image quality was inferred indirectly from fluoroscopy time and frames rather than formally rated.
Related research summaries
- Fluoroscopy-minimization strategy for catheter ablation of Supraventricular Tachycardia by wOmen OPerators: the STOOP Multicentre Registry (2026, Prospective cohort study)
- Decreased Operator X-Ray Exposure By Optimized Fluoroscopy During Radiofrequency Ablation Of Common Atrial Flutter (2018, Prospective cohort study)
- Reducing radiation exposure during procedures performed in the electrophysiology laboratory (2017, Retrospective cohort study)
- Near zerO fluoroscopic exPosure during catheter ablAtion of supRavenTricular arrhYthmias: the NO-PARTY multicentre randomized trial (2015, Randomized trial)
- Radiation exposure during cardiac device implantation: Lessons learned from a multicenter registry (2019, Prospective cohort study)
How this summary was made
ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.
Prepared November 3, 2026.